US-based BCM ties up with India’s’ BE for COVID-19 immunization production Kumar Jeetendra | August 28, 2020 Houston, Aug 28 (PTI) At the race to discover a cure for its coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing arrangement with Indian pharmaceutical company Biological E Limited (BE) for the growth of a secure, effective and inexpensive vaccine. The business engaged in licence negotiations with all the BCM …
Oxford covid antibody: No reactions seen as more volunteers get Covishield in India Kumar Jeetendra | August 28, 2020 Five volunteers were given Oxford covid-19 vaccine at Pune district Thursday as part of this phase II clinical trial. Three of these volunteers have been administered the Oxford COVID-19 vaccine candidate in Bharti Vidyapeeth’s Medical College and Hospital at Pune town while two more volunteers were inoculated with the Oxford COVID-19 vaccine candidate at the …
India may get COVID-19 antibody by mid 2021: Bernstein Kumar Jeetendra | August 28, 2020 India is likely to acquire an approved COVID-19 vaccine by the first quarter of 2021, global brokerage firm Bernstein said in a report. “We’re optimistic that there will be an approved vaccine in the marketplace by 1Q calendar year 2021 in India,” the report stated. While the vaccine may be available at USD 3-6 (Rs …
FDA cautions customers about liquor based hand sanitizers bundled in containers Kumar Jeetendra | August 27, 2020 The U.S. Food and Drug Administration (FDA) is warning consumers around alcohol-based hand sanitizers which are being packaged in containers that may seem as food or beverages and might place users at risk of severe harm or death when ingested. The bureau has found that some hand sanitizers are being packaged in beer cans, children’s …
Possible connect to brain irritation may clarify the association among MS and exhaustion Kumar Jeetendra | August 27, 2020 As much as 60 percent of individuals with multiple sclerosis (MS) report that fatigue is that the disease’s most distressing symptom. And fatigue remains among MS’s puzzles — despite its incidence and significance, the root cause of this symptom remains unclear. In a study published in Neurology Neuroimmunology & Neuroinflammation, investigators from Brigham and Women’s …
Abbott’s card-sized 15-minute COVID-19 test gets USFDA gesture for emergency use Kumar Jeetendra | August 27, 2020 Abbott intends to send tens of millions of tests from September, ramping to 50 million tests a month at the beginning of October. BinaxNOW is the size of a credit card and gives results in 15 minutes. Abbott intends to market this evaluation for 5 (approx Rs 370), making it more reasonably priced than a …
Japanese scientists may have discovered a viable method to kill COVID infection Kumar Jeetendra | August 27, 2020 Researchers at Japan on August 26 said low concentrations of ozone may neutralise particles of the coronavirus. This is being regarded as a potential method for hospitals to disinfect test rooms and waiting areas. Researchers at the Fujita Health University informed a news conference they had demonstrated that ozone gas in concentrations of 0.05 to …
Untreated wastewater tests from Louisiana contain SARS-Cov-2 RNA Kumar Jeetendra | August 26, 2020 A group of scientists have detected genetic material from SARS-CoV-2 in untreated wastewater samples collected in April 2020 from two wastewater treatment plants in Louisiana, USA. Wastewater-Based Epidemiology (WBE) is a process where the spread of illness in human populations is monitored by analyzing wastewater. It’s been used to track the spread of polio and …
China manages exploratory COVID-19 antibodies to high-chance gatherings since a month, says official Kumar Jeetendra | August 26, 2020 China has been tackling experimental COVID-19 vaccines to teams facing high infection risks since July, a health official told the state . No vaccine has passed final, large-scale trials to show it is safe and effective enough to protect people from contracting the virus which has led to nearly 800,000 deaths worldwide. The purpose is …
Stage 2 human preliminary of Oxford antibody may begin from August 26 in Pune Kumar Jeetendra | August 25, 2020 The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII). “To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted …
Coronavirus re-contaminations raise worries about resistance Kumar Jeetendra | August 25, 2020 Two European sufferers are verified to have been re-infected with the coronavirus, raising concerns about people’s immunity to the virus since the world struggles to tame the pandemic. The cases, in Belgium and the Netherlands, follow a report this week by researchers at Hong Kong to a guy there who was re-infected using a different …
Blood Pressure may improve COVID-19 endurance rates, study says Kumar Jeetendra | August 24, 2020 Medicine for high blood pressure might improve COVID-19 survival rates, and reduce the seriousness of novel coronavirus disease, especially in patients with hypertension, according to a study. Researchers from the University of East Anglia (UEA) in the UK analyzed 28,000 patients taking antihypertensives — a category of drugs which are used to treat hypertension or …
